about
Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a reviewChromatographic studies of changes in binding of sulfonylurea drugs to human serum albumin due to glycation and fatty acids.Glipizide, an antidiabetic drug, suppresses tumor growth and metastasis by inhibiting angiogenesis.Discovery of DS-1558: A Potent and Orally Bioavailable GPR40 AgonistDiabetic nephropathy amelioration by a low-dose sitagliptin in an animal model of type 2 diabetes (Zucker diabetic fatty rat).N-Acetylfarnesylcysteine is a novel class of peroxisome proliferator-activated receptor γ ligand with partial and full agonist activity in vitro and in vivo.Glipizide suppresses prostate cancer progression in the TRAMP model by inhibiting angiogenesisPPARgamma and its ligands: therapeutic implications in cardiovascular disease.Effects of sulfonylureas on tumor growth: a review of the literature.Novel DPP-4 inhibitors against diabetes.Free fatty acid receptor agonists for the treatment of type 2 diabetes: drugs in preclinical to phase II clinical development.Glibenclamide treatment blocks metabolic dysfunctions and improves vagal activity in monosodium glutamate-obese male rats.New insights into antidiabetic drugs: Possible applications in cancer treatment.Enhancing antidiabetic and antimicrobial performance of Ocimum basilicum, and Ocimum sanctum (L.) using silver nanoparticles.Metabonomic analysis of the therapeutic effect of Potentilla discolor in the treatment of type 2 diabetes mellitus.Comparison of metformin, gliclazide MR and rosiglitazone in monotherapy and in combination for type 2 diabetes.Preparation and crystallographic analysis of gliclazide polymorphs.Design, synthesis, biological evaluation, and docking studies of (s)-phenylalanine derivatives with a 2-cyanopyrrolidine moiety as potent dipeptidyl peptidase 4 inhibitors.Glipizide sensitizes lung cancer cells to TRAIL-induced apoptosis via Akt/mTOR/autophagy pathways.Revisiting the Therapeutic Potential of Bothrops jararaca Venom: Screening for Novel Activities Using Connectivity Mapping.Effectiveness of adding vildagliptin to the treatment of diabetic patients nonresponsive to the combination of metformin and a sulphonylurea.Development of an In Vitro Screening Platform for the Identification of Partial PPARγ Agonists as a Source for Antidiabetic Lead CompoundsConformational polymorphism of the antidiabetic drug chlorpropamide
P2860
Q24561401-DFCA2E53-E160-46FB-8752-388176B2D61EQ34288470-34F8F922-2BAB-46E0-8E43-450C9BD6208FQ34654807-ECED66DC-D349-494C-80BF-E0FB8B71509EQ35178871-D2169F22-9B52-4220-B292-724D7BF7656DQ35607330-45ECB996-D72E-43B4-AE5E-6DBF41D817A4Q35842216-D49F3111-9733-4926-B60F-A87D904671CDQ36996141-881B5766-DA78-4BD2-8EBA-AFA1FF9DEB6EQ37179467-4722531F-D0DE-49DA-B490-30A0EC399551Q37247194-F20C3AAE-495F-4632-9054-8A4E4F166705Q38221278-D9901B48-A7BB-4D47-9796-5BCC288B5707Q38832716-7F45DA10-E11E-45B8-9AC6-D4E407CA471EQ38944880-069D5E3A-FC0F-4EDF-8FEA-87B1254019E2Q39272833-8ED2788D-5F5F-4E17-8960-5DD1A053D2A5Q40073859-3DCFA405-D714-4DAB-8156-998E6DF7FD7FQ42202080-8E9D620B-7BAB-4121-8CAC-35D72E7B93C7Q43045655-B6422327-57D3-4D75-AEC3-4928E31384DAQ43182734-2E9FC382-E517-4F97-BDE4-FD40F750E14DQ46415265-3C1C083F-D305-416F-997B-C74EBD9D3BD2Q47289111-7A89398B-1286-430D-9674-67813499DA7DQ48507956-90A78312-00D7-402F-853A-0AB0AF2AB622Q51370472-1DE9C93E-0B00-4DE0-A56F-CA250A63981DQ58696993-B848E338-1A20-4F55-BB30-B191BE447B3AQ58860604-7CF9A028-3E82-4866-9321-AE23A36E146C
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Type 2 diabetes and oral antihyperglycemic drugs.
@en
Type 2 diabetes and oral antihyperglycemic drugs.
@nl
type
label
Type 2 diabetes and oral antihyperglycemic drugs.
@en
Type 2 diabetes and oral antihyperglycemic drugs.
@nl
prefLabel
Type 2 diabetes and oral antihyperglycemic drugs.
@en
Type 2 diabetes and oral antihyperglycemic drugs.
@nl
P2093
P1476
Type 2 diabetes and oral antihyperglycemic drugs.
@en
P2093
Amar G Chittiboyina
Cassia S Mizuno
Harrihar A Pershadsingh
Mitchell A Avery
Theodore W Kurtz
P356
10.2174/092986708783330656
P577
2008-01-01T00:00:00Z